Marco Valgimigli

Research interests

Publications

• Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC

  European Heart Journal · 2021 · https://doi.org/10.1093/eurheartj/ehab648

• Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk

  New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2108749

• Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

  Journal of the American College of Cardiology · 2020 · https://doi.org/10.1016/j.jacc.2020.11.010

• 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

  European Heart Journal · 2019 · https://doi.org/10.1093/eurheartj/ehz425

• Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention

  Circulation · 2019 · https://doi.org/10.1161/circulationaha.119.040167

• 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

  European Heart Journal · 2019 · https://doi.org/10.1093/eurheartj/ehz425

• Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk

  European Heart Journal · 2019 · https://doi.org/10.1093/eurheartj/ehz372

• European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism

  European Heart Journal · 2018 · https://doi.org/10.1093/eurheartj/ehy649

• Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

  The Lancet · 2018 · 10.1016/s0140-6736(18)31858-0

• 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

  European Heart Journal · 2017 · 10.1093/eurheartj/ehx419

• 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

  European Heart Journal · 2017 · https://doi.org/10.1093/eurheartj/ehx393

• Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials

  The Lancet · 2017 · 10.1016/s0140-6736(17)30397-5

• Linee guida ESC 2015 per il trattamento delle sindromi coronariche acute nei pazienti senza sopraslivellamento persistente del tratto ST alla presentazione. Task Force per il Trattamento delle Sindromi Coronariche Acute nei Pazienti senza Sopraslivellamento Persistente del Tratto ST alla Presentazione della Società Europea di Cardiologia (ESC)

  Giornale italiano di cardiologia · 2016 · 10.1714/2464.25804

• 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

  European Heart Journal · 2015 · https://doi.org/10.1093/eurheartj/ehv320

• Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial

  The Lancet · 2015 · 10.1016/s0140-6736(15)60292-6

• 2014 ESC/EACTS Guidelines on myocardial revascularization

  European Journal of Cardio-Thoracic Surgery · 2014 · 10.1093/ejcts/ezu366

• ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

  European Heart Journal · 2012 · 10.1093/eurheartj/ehs215

• Standardized Bleeding Definitions for Cardiovascular Clinical Trials

  Circulation · 2011 · 10.1161/circulationaha.110.009449

• Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents

  New England Journal of Medicine · 2007 · 10.1056/nejmoa067484

• Distal Left Main Coronary Disease Is a Major Predictor of Outcome in Patients Undergoing Percutaneous Intervention in the Drug-Eluting Stent Era

  Journal of the American College of Cardiology · 2006 · https://doi.org/10.1016/j.jacc.2005.11.066

• Long-Term Outcomes After Stenting of Bifurcation Lesions With the “Crush” Technique

  Journal of the American College of Cardiology · 2006 · https://doi.org/10.1016/j.jacc.2005.11.083

• Coronary artery remodelling is related to plaque composition

  Heart · 2005 · https://doi.org/10.1136/hrt.2004.057810

• The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population

  Journal of the American College of Cardiology · 2005 · https://doi.org/10.1016/j.jacc.2005.01.008

• Short- and Long-Term Clinical Outcome After Drug-Eluting Stent Implantation for the Percutaneous Treatment of Left Main Coronary Artery Disease

  Circulation · 2005 · https://doi.org/10.1161/01.cir.0000158486.20865.8b

• In Vivo Intravascular Ultrasound-Derived Thin-Cap Fibroatheroma Detection Using Ultrasound Radiofrequency Data Analysis

  Journal of the American College of Cardiology · 2005 · https://doi.org/10.1016/j.jacc.2005.07.064

Current projects

No projects listed.